| Targeting tumor-associated fibroblasts for therapeutic delivery in desmoplastic tumors L Miao, Q Liu, CM Lin, C Luo, Y Wang, L Liu, W Yin, S Hu, WY Kim, ... Cancer research 77 (3), 719-731, 2017 | 207 | 2017 |
| Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling S Hu, DZ D’Argenio Journal of pharmacokinetics and pharmacodynamics 47, 385-409, 2020 | 26 | 2020 |
| Natural particulates inspired specific-targeted codelivery of siRNA and paclitaxel for collaborative antitumor therapy R Wang, Z Zhao, Y Han, S Hu, Y Opoku-Damoah, J Zhou, L Yin, Y Ding Molecular pharmaceutics 14 (9), 2999-3012, 2017 | 16 | 2017 |
| Physiologically based modeling to predict monoclonal antibody pharmacokinetics in humans from in vitro physiochemical properties S Hu, A Datta-Mannan, DZ D’Argenio MAbs 14 (1), 2056944, 2022 | 15 | 2022 |
| An analysis of glucose effectiveness in subjects with or without type 2 diabetes via hierarchical modeling S Hu, Y Lu, A Tura, G Pacini, DZ D’Argenio Frontiers in Endocrinology 12, 641713, 2021 | 6 | 2021 |
| Monoclonal antibody pharmacokinetics in cynomolgus monkeys following subcutaneous administration: physiologically based model predictions from physiochemical properties S Hu, A Datta-Mannan, DZ D’Argenio The AAPS Journal 25 (1), 5, 2022 | 4 | 2022 |
